ABOUT DIAMYD MEDICAL
ABOUT DIAMYD MEDICAL
CEO Comments
The Diamyd Story
Board & Management
Contact Us
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
Diamyd US Operations
Partnering
DIABETES
DIABETES
Type 1
LADA
Type 2
Complications
Diamyd
®
Products
PRODUCTS & PIPELINE
PRODUCTS & PIPELINE
Diamyd
®
Products
Diamyd
®
for type 1
Diamyd
®
for LADA
NTDDS products
NP2
NG2
NC3
Partnering
SCIENCE & TECHNOLOGY
SCIENCE & TECHNOLOGY
GAD platform
NTDDS platform
Clinical development
Scientific publications
Scientific advisory board
CLINICAL TRIALS
CLINICAL TRIALS
Phase III Trials - USA
Phase III Trials - Europe
INVESTOR RELATIONS
INVESTOR RELATIONS
Press Releases
Financial Reports
IR Calendar
Owners
Share Trading
Board & Management
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
PRESS ROOM
PRESS ROOM
Press Releases
News & Mediawatch
Webcasts/Podcasts
Newsletter Subscription
Media Contact
Home
»
News & Mediawatch
»
Diamyd presenterar på kapitalmarknadsdag 3 september
News & Mediawatch
Latest news on Diamyd Medical activities and events and links to news sources related to Diamyd Medical.
August 28, 2009 - Sweden
Diamyd presenterar på kapitalmarknadsdag 3 september
Diamyd Medical presenterar på Stockholm Corporate Finance Small Cap dag den 3 september 2009. Symposiet är ett heldagsarrangemang på Operaterrassen med syftet att erbjuda investerare, media och analytiker ett tidseffektivt sätt att träffa intressanta bolag. Pontus Herin från Veckans Affärer kommer att vara moderator och leda frågestunder med de presenterande bolagen.
Läs mer och anmäl er här:
http://www.financialhearings.com/
Attached file:
financialhearings_2009.pdf
More articles
Press Room
Press Releases
News & Mediawatch
Webcasts/Podcasts
Newsletter Subscription
Media Contact
Subscribe to News & Mediawatch